There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Absci Corporation (ABSI) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.06, or 2.08%, to $2.94. The Absci Corporation has recorded 6,176 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI.
As a NASDAQ listed company, ABSI falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $2.88 and fluctuated between $2.9500 as its day high and $2.7600 as its day low. The current market capitalization of Absci Corporation is $260.61M. A total of 0.24 million shares were traded on the day, compared to an average of 355.17K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, ABSI has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 50,000 and the disposition of 0 shares. Over the last 12 months, there were 4 BUYs and 0 SELLs from insiders. Insiders purchased 63,405 shares during that period but sold 0.
In the most recent transaction, Korman Sarah bought 4,250 shares of ABSI for 7.96 per share on Feb 09. After the transaction, the General Counsel now owns 14,250 company shares. In a previous transaction on Jan 20, Bedrick Todd bought 2,000 shares at 7.50 per share. ABSI shares that VP, CCPAO owns now total 3,000.
Among the insiders who bought shares, McClain Sean acquired of 7,155 shares on Jan 19 at a per-share price of $6.92. This resulted in the President and Chief Executive holding 6,368,955 shares of ABSI after the transaction.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for ABSI in the last 3 months, the mean price target is $12.00 with high estimates of $28.00 and low estimates of $3.00. In terms of 52-week highs and lows, ABSI has a high of $9.68 and a low of $1.94.
As of this writing, ABSI has an earnings estimate of -$0.28 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.23 per share and a lower estimate of -$0.32. The company reported an EPS of -$0.33 in the last quarter, which was -13.80% lower than expectations of -$0.29.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 7 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABSI is Overweight with a score of 3.50. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 1 thought it should be Sold.